Colgate-Palmolive Q2 2026 Sales Rise to $5.36 Billion Surpassing Estimates

Key Facts

1Colgate-Palmolive reported Q2 2026 sales of $5.36 billion, a 4.9% year-over-year increase.

2Base business EPS reached $0.99, surpassing the analyst consensus of $0.95.

Colgate-Palmolive reported Q2 2026 sales of $5.36 billion, representing a 4.9% year-over-year increase. Reuters reported that the company's base business EPS reached $0.99, surpassing the analyst consensus of $0.95.

CL shares closed at $84.26 on October 2, 2026, with the session seeing a trading range between a low of $83.99 and a high of $84.83. The financial performance was supported by strong operational results and revenue growth, although the stock remains below its 52-week high.